Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability

Biochemical and Biophysical Research Communications

Volumn 345, Issue 1, 2006, Pages 486-494

  Zhou, Huimin ^a   Jia, Li ^a   Wang, Shujing ^a   Wang, Hongmei ^a,b   Chu, Haiying ^a   Hu, Yichuan ^a   Cao, Jun ^a   Zhang, Jianing ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b Liaodong College   (China)

Author keywords

Caveolin 1; Hepatocarcinoma; Lymphatic metastasis; VEGFA

Indexed keywords

CAVEOLIN 1; CHOLESTEROL; MESSENGER RNA; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CARCINOGENESIS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GROWTH REGULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CAVEOLIN 1; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MICE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 33646415976     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.246     Document Type: Article

References (39)

1. Fujimoto T., Kogo H., Nomura R., and Une T. Isoforms of caveolin-1 and caveolar structure. J. Cell Sci. 113 (2000) 3509-3517
2. Engelman J.A., Lee R.J., Karnezis A., Bearss D.J., Webster M., Siegel P., Muller W.J., Windle J.J., Pestell R.G., and Lisanti M.P. Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. J. Biol. Chem. 273 (1998) 20448-20455
3. Smart E.J., Ying Y., Donzell W.C., and Anderson R.G. A Role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271 (1996) 29427-29435
4. Schnitzer J.E., Oh P., and McIntosh D.P. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 274 (1996) 239-242
5. Okamoto T., Schlegel A., Scherer P.E., and Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273 (1998) 5419-5422
6. Lee S.W., Reimer C.L., Oh P., Campbell D.B., and Schnitzer J.E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16 (1998) 1391-1397
7. Williams T.M., and Lisanti M.P. The caveolin proteins. Genome Biol. 5 (2004) 214
8. Bender F., Montoya M., Monardes V., Leyton L., and Quest A.F. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35 (2002) 139-150
9. Williams T.M., Medina F., Badano I., Hazan R.B., Hutchinson J., Muller W.J., Chopra N.G., Scherer P.E., Pestell R.G., and Lisanti M.P. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 279 (2004) 51630-51646
10. Bender F.C., Reymond M.A., Bron C., and Quest A.F. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res. 60 (2000) 5870-5878
11. Wiechen K., Diatchenko L., Agoulnik A., Scharff K.M., Schober H., Arlt K., Zhumabayeva B., Siebert P.D., Dietel M., Scähfer R., and Sers C. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159 (2001) 1635-1643
12. Razani B., Schlegel A., Liu J., and Lisanti M.P. Caveolin-1, a putative tumour suppressor gene. Biochem. Soc. Trans. 29 (2001) 494-499
13. Yang G., Truong L.D., Wheeler T.M., and Thompson T.C. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 59 (1999) 5719-5723
14. Ho C.C., Huang P.H., Huang H.Y., Chen Y.H., Yang P.C., and Hsu S.M. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol. 161 (2002) 1647-1656
15. Davidson B., Nesland J.M., Goldberg I., Kopolovic J., Gotlieb W.H., Bryne M., Baruch G.B., Berner A., and Reich R. Caveolin-1 expression in advanced-stage ovarian carcinoma-a clinicopathologic study. Gynecol. Oncol. 81 (2001) 166-171
16. Joo H.J., Oh D.K., Kim Y.S., Lee K.B., and Kim S.J. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int. 93 (2004) 291-296
17. Kato K., Hida Y., Miyamoto M., Hashida H., Shinohara T., Itoh T., Okushiba S., Kondo S., and Katoh H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94 (2002) 929-933
18. Wu C., Butz S., Ying Y.S., and Anderson R.G. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J. Biol. Chem. 272 (1997) 3554-3559
19. Labrecque L., Royal I., Surprenant D.S., Patterson C., Gingras D., and Beliveau R. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell 14 (2003) 334-347
20. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., Betsholtz C., and Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 (2004) 74-80
21. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., and Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201 (2005) 1089-1099
22. Bauer P.M., Yu J., Chen Y., Hickey R., Bernatchez P.N., Looft-Wilson R., Huang Y., Giordano F., Stan R.V., and Sessa W.C. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc. Natl. Acad. Sci. USA 102 (2005) 204-209
23. Hou L., Li Y., Jia Y.H., Wang B., Xin Y., Ling M.Y., and Lu S. Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. World J. Gastroenterol. 7 (2001) 532-536
24. Li H.F., Ling M.Y., Xie Y., and Xie H. Establishment of a lymph node metastatic model of mouse hepatocellular carcinoma Hca-F cells in C3H/Hej mice. Oncol. Res. 10 (1998) 569-573
25. Syed V., Mukherjee K., Lyons-Weiler J., Lau K.M., Mashima T., Tsuruo T., and Ho S.M. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24 (2005) 1774-1787
26. Song B., Tang J.W., Wang B., Cui X.N., Hou L., Sun L., Mao L.M., Zhou C.H., Du Y., Wang L.H., Wang H.X., Zheng R.S., and Sun L. Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chip. World J. Gastroenterol. 11 (2005) 1463-1472
27. Galbiati F., Volonté D., Engelman J.A., Watanabe G., Burk R., Pestell R.G., and Lisanti M.P. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17 (1998) 6633-6648
28. Carman C.V., Lisanti M.P., and Benovic J.L. Regulation of G protein-coupled receptor kinases by caveolin. J. Biol. Chem. 274 (1999) 8858-8864
29. Tahir S.A., Yang G., Ebara S., Timme T.L., Satoh T., Li L., Goltsov A., Ittmann M., Morrisett J.D., and Thompson T.C. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61 (2001) 3882-3885
30. Yang G., Timme T.L., Frolov A., Wheeler T.M., and Thompson T.C. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer 103 (2005) 1186-1194
31. Lavie Y., Fiucci G., and Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273 (1998) 32380-32383
32. Achen M.G., McColl B.K., and Stacker S.A. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7 (2005) 121-127
33. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2 (2002) 573-583
34. Chang L.K., Garcia-Cardeña G., Farnebo F., Fannon M., Chen E.J., Butterfield C., Moses M.A., Mulligan R.C., Folkman J., and Kaipainen A. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc. Natl. Acad. Sci. USA 101 (2004) 11658-11663
35. Feng Y., Venema V.J., Venema R.C., Tsai N., Behzadian M.A., and Caldwell R.B. VEGF-induced permeability increase is mediated by caveolae. Invest. Ophthalmol. Vis. Sci. 40 (1999) 157-167
36. Liu J., Wang X.B., Park D.S., and Lisanti M.P. Caveolin-1 expression enhances endothelial capillary tubule formation. J. Biol. Chem. 277 (2002) 10661-10668
37. Williams T.M., Hassan G.S., Li J., Cohen A.W., Medina F., Frank P.G., Pestell R.G., Di V.D., Loda M., and Lisanti M.P. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J. Biol. Chem. 280 (2005) 25134-25145
38. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., Macaluso F., Russell R.G., Li M., Pestell R.G., Di V.D., Hou H., Kneitz B., Lagaud G., Christ G.J., Edelmann W., and Lisanti M.P. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276 (2001) 38121-38138
39. Lipardi C., Mora R., Colomer V., Paladino S., Nitsch L., Rodriguez-boulan E., and Zurzolo C. Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J. Cell Biol. 140 (1998) 617-626